Spinocerebellar degenerations--clinical aspects and new treatment of ataxia.
D000328:Adult; D000818:Animals; D001284:Atrophy; D002524:Cerebellar Ataxia / Q000188:drug therapy*; D002531:Cerebellum / Q000473:pathology*; D004311:Double-Blind Method; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D005260:Female; D005621:Friedreich Ataxia / Q000188:drug therapy; D006801:Humans; D008297:Male; D051379:Mice; D008818:Mice, Neurologic Mutants; D008875:Middle Aged; D010300:Parkinson Disease / Q000150:complications; D012791:Shy-Drager Syndrome / Q000150:complications; D013973:Thyrotropin-Releasing Hormone / Q000627:therapeutic use*
D013973:Thyrotropin-Releasing Hormone